ICU Medical (ICUI) Tops Q1 EPS by 13c, Reaffirms Guidance

ICU Medical (NASDAQ: ICUI) reported Q1 EPS of $1.14, $0.13 better than the analyst estimate of $1.01. Revenue for the quarter came in at $89.9 million versus the consensus estimate of $88.04 million.

Fiscal Year 2016 Guidance

For the year, the Company is reiterating its 2016 guidance. It expects revenue to be in the range of $355 million to $365 million; adjusted diluted earnings per share to be in the range of $4.34 to $4.46, and adjusted EBITDA to be in the range of $123 million to $127 million.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance